RARE vs SNDR · rev $350.0M vs P/E 36, rev $2.97B
Ultragenyx (RARE) versus Schneider National Inc (SNDR) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Schneider National Inc (SNDR) is a trucking company listed on US.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported SNDR revenue for 2026-06-30 was $2.97B. Net income was $70.1M. SNDR currently screens at market cap $4.50B and trailing P/E 36.1.
RARE currently screens at market cap $2.79B. SNDR currently screens at market cap $4.50B and trailing P/E 36.1.
Not investment advice. Open the RARE and SNDR stock pages for the full models.
Not investment advice.